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Abstract
Partial inactivation of the Ankyrin repeat domain 26 (Ankrd26) gene causes obesity and diabetes in mice and increases
spontaneous and induced adipogenesis in mouse embryonic fibroblasts. However, it is not yet known how the Ankrd26
protein carries out its biological functions. We identified by yeast two-hybrid and immunoprecipitation assays the triple
functional domain protein (TRIO), the G protein pathway suppressor 2 (GPS2), the delta-interacting protein A (DIPA) and the
hyaluronan-mediated motility receptor (HMMR) as ANKRD26 interacting partners. Adipogenesis of 3T3-L1 cells was
increased by selective down-regulation of Ankrd26, Trio, Gps2, Hmmr and Dipa. Furthermore, GPS2 and DIPA, which are
normally located in the nucleus, were translocated to the cytoplasm, when the C-terminus of ANKRD26 was introduced into
these cells. These findings provide biochemical evidence that ANKRD26, TRIO, GPS2 and HMMR are novel and important
regulators of adipogenisis and identify new targets for the modulation of adipogenesis.
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Introduction
The current epidemic of obesity and diabetes has stimulated
research to improve the understanding of these diseases and to
identify and characterize new genes involved in their pathogenesis
[1–5]. We recently demonstrated that the Ankyrin repeat domain 26
(Ankrd26) gene plays an important role in the development of these
pathologies. Mice with partial inactivation of the Ankrd26 gene
develop marked hyperphagia, severe obesity and an unusual form
of diabetes in which white adipose tissue preserves its sensitivity to
insulin [6,7]. Moreover, when young Ankrd26 deficient mice were
placed on a pair-feeding diet with normal mice, they maintained
normal body weight, showed a better glucose tolerance, and
increased insulin sensitivity in the white adipose tissue, indicating a
dual role of the Ankrd26 gene in the control of appetite and of
adipose tissue insulin sensitivity [7]. In addition, mouse embryonic
fibroblasts (MEFs) from these mice have a higher rate of
spontaneous adipogenesis compared to normal MEFs and their
differentiation to adipocytes is greatly increased when they are
exposed to a mixture of adipogenic inducers [8], indicating a
prominent role of the Ankrd26 gene in fat cells.
The Ankrd26 protein is highly expressed in the hypothalamus
and other regions of the brain, as well as in many tissues and
organs, including white adipose tissue. The protein is located in
the cytosol close to the inner aspect of the cell membrane in HeLa
and 293T cells expressing ANKRD26-EGFP, and it contains both
ankyrin repeats and spectrin helices, through which it is potentially
able to interact with other proteins [6]. However, it is not yet
known what these proteins are and how the Ankrd26 protein
carries out its biological functions.
In the present work, we used yeast two-hybrid and immuno-
precipitation assays to identify interacting partners for the
Ankrd26 protein, and performed knock-down experiments to
establish whether any of these interacting proteins were function-
ally relevant in adipogenesis and whether this process was carried
out by their interaction with Ankrd26 protein.
Results
Identification of ANKRD26 protein interaction partners
To identify potential interacting partners of the ANKRD26
protein, we performed yeast two-hybrid screening using 18 baits,
encoding overlapping fragments from the full-length ANKRD26
protein sequence (Figure 1). The baits were screened with three
different cDNA expression libraries generated from human adult
brain, human testis and mouse 11.5-day embryo, tissues known to
express ANKRD26 [6]. Thirteen independent interacting proteins
were identified by the screening, and 12 of them bound to the
coiled-coil domain in the C-terminus, suggesting a prominent role
of this domain for Ankrd26 protein-protein interactions (Table 1).
Validation of ANKRD26 protein interaction partners by IP
Among the 13 interacting partners, we selected five to validate
their interactions with ANKRD26 in mammalian cells. These are
the triple functional domain protein (Trio), G-protein pathway
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e38130suppressor 2 (Gps2), delta interacting protein A (DIPA; also called
coiled-coil domain-containing protein 85B, Ccdc85b), hyaluro-
nan-mediated motility receptor (HMMR), and Ras association
(RalGDS/AF-6) domain family (N-terminal) member 7 (Rassf7;
also referred to as LOC66985). Because all five partners interact
with the C-terminus region of ANKRD26, we generated an
expression plasmid containing the last 498 amino acids of human
ANKRD26 (1212–1710 fragment) fused to a FLAG epitope tag
located at the N-terminus of the protein (Flag-ANKRD26-C).
Then a series of IP assays were performed in 293/T cells
transiently co-transfected with Flag-ANKRD26-C and with
different vectors, each expressing one of the selected proteins. IP
analysis confirmed positive interactions for TRIO, GPS2, DIPA,
and HMMR (Figure 2). No interaction was observed for Rassf7
(data not shown).
ANKRD26/TRIO interaction by IP
Among the 13 interacting candidates, TRIO was pulled out
once during the two-hybrid screening from the mouse embryo c-
DNA library (Table 1). TRIO is a triple functional domain protein
that promotes Ras homolog gene family (Rho) and Ras-related C3
botulinum toxin substrate 1 (Rac1) activation through the
exchange of GDP by GTP [9]. Also with the protein tyrosine
phosphatase (LAR) it plays a role in coordinating cell-matrix and
cytoskeletal rearrangements necessary for cell migration and cell
growth [10,11]. To validate the TRIO interaction with
Figure 1. ANKRD26 yeast two-hybrid strategy. The position of ANKRD26’s ankyrin and spectrin coiled-coil repeats are depicted on a schematic
diagram of the full-length, 1710 amino acid, protein. The line below indicates the relative locations of ANKRD26 bait clones used in the GAL4-based
yeast two-hybrid cDNA library screens. DIPA interacts with baits 7, 8, 9 and 17; GPS2 interacts with bait 17; HMMR interacts with baits 9 and 17; and
TRIO interacts with bait 10.
doi:10.1371/journal.pone.0038130.g001
Table 1. Interactors for ANKRD26 identified by yeast two-hybrid screening.
cDNA Library Identity
ANKRD26 Interacting
Region (aa residues) Description Frequency
{ Confirmed
{
Human brain ANKRD17 1–199 Ankyrin repeat domain 17 1 ND
1
Human testis ANKRD18B 1320–1535 Ankyrin repeat domain 18B 3 ND
C10RF9 1320–1535 Chromosome 1 open reading frame 9, isoform 1 1 ND
GCC2 1344–1638 GRIP and coiled-coil domain containing 2, isoform a 1 ND
LOC375010 1320–1535 Hypothetical protein 1 ND
Mouse 11.5 days
embryo
Ccdc85b 1090–1638 Coiled-coil domain containing 85B 4 Yes
Cxxc1 901–1100 CXXC finger 1 1 ND
Fb1 1320–1535 Fb1 1 ND
Gps2 1320–1535 G protein pathway suppressor 2 2 Yes
HMMR 1320–1638 Hyaluron mediated motility receptor 2 Yes
LOC66985 1344–1638 Rassf7 Ras association (RalGDS/AF-6) domain family 7 1 No
Trio 1519–1702 Triple functional domain (PTPRF interacting), isoform 5 1 Yes
Sdccag8 1090–1287 Serologically defined colon 1 ND
{Frequency: number of times pulled out during the two-hybrid screening.
{Confirmed: confirmation of screening results by co-immunoprecipitation.
1ND: not done.
doi:10.1371/journal.pone.0038130.t001
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(aa 773–1059) into a pcDNA3.1 vector with a myc-epitope tag and
co-transfected it with pFlag-ANKRD26-C into 293/T cells.
Whole cell extracts were immunoprecipitated with anti-Myc
antibody followed by immunoblot analysis with both anti-Flag
and anti-Myc antibodies. Figure 2A shows that both TRIO-Myc
(lane 2) and Flag-ANKRD26-C (lanes 5 and 6) proteins were
expressed in 293T cells, and that the Flag-ANKRD26-C protein
was efficiently immunoprecipitated by TRIO-Myc protein (lane
8), validating their interaction in mammalian cells.
ANKRD26/GPS2 interaction By IP
GPS2 was pulled out two times from the mouse 11.5-day
embryo cDNA library (Table 1). GPS2 is a protein involved in
suppressing G-protein- and mitogen-activated protein kinase-
mediated signal transduction [12,13], and has been described as
an integral subunit of the transcriptional repressor Nuclear
CoRepressor-Hystone DeAcetylase 3 (N-CoR-HDAC3) complex
[14]. To validate its interaction with ANKRD26 we co-transfected
the Flag-ANKRD26-C and the Myc-tagged GPS2 vectors into
293/T cells and performed IP experiments, as described above.
Figure 2B shows both proteins are detected in transfected 293/T
cells (lanes 2, 5 and 6) and that the anti-Myc antibody efficiently
pulled down Flag-ANKRD26-C protein as shown by the
immunoblot with anti-Flag antibody (lane 8), validating the
GPS2/ANKRD26-C interaction.
ANKRD26/DIPA interaction by IP
DIPA was pulled out four times from a mouse 11.5-day embryo
cDNA expression library (Table 1). DIPA, encoded by the
CCDC85B gene, has a structural homology to hepatitis delta
virus antigen (HDAg) [15]. DIPA has been reported as an
inhibitory partner of the CCAAT-enhancer-binding protein (C/
EBP)b and d and has been implicated in adipocyte differentiation
[16]. We co-transfected the Flag-ANKRD26-C expression vector
with a Myc epitope tagged DIPA (DIPA-Myc) vector into 293/T
cells. As shown in Figure 2C, DIPA-Myc and Flag-ANKRD26-C
proteins are well expressed in 293T cell (lanes 2, 5 and 6), and the
IP for the DIPA-Myc fragment specifically pulled down Flag-
ANKRD26-C protein (lane 8). Similar results were obtained for IP
experiment using an EGFP tagged ANKRD26-C construct (data
not shown). Both data validate that a DIPA/ANKRD26-C
interaction can occur in mammalian cells.
ANKRD26/HMMR interaction by IP
During the two-hybrid screening HMMR was pulled out two
times from the mouse 11.5-day embryo cDNA library (Table 1).
The HMMR gene encodes a protein with a dual action. Within
the cell it associates with microtubules and plays a role in the
regulation of mitosis [17], while when released into the extracel-
lular space, it can activate intracellular signaling pathways upon
association with CD44 and hyaluronan [18]. Its interaction with
ANKRD26 was validated by co-transfecting the Flag-ANKRD26-
C vector and the Myc-tagged HMMR vector into 293/T cells. As
shown in Figure 2D, both HMMR-Myc and Flag-ANKRD26-C
proteins are detectable in transfected 293/T cells (lanes 2, 5 and 6)
and the anti-Myc antibody efficiently pulled down Flag-
ANKRD26-C (lane 8).
Role of Ankrd26, Trio, Gps2, Hmmr and Dipa in
adipogenesis
Because ablation of the C-terminus of Ankrd26 modulates
adipogenesis in MEFs [8], we sought to establish whether Ankrd26
and/or any of its interacting partners have a role in differentiation
of 3T3-L1 cells, which are widely used for adipogenesis
differentiation studies [19]. The transduction of 3T3-L1 cells with
a specific shRNA for Ankrd26 (Ankrd-sh) resulted in a 65%
reduction of Ankrd26 mRNA compared to parental 3T3-L1 cells
transfected with a non-specific shRNA (Co-sh) (Figure 3A). When
differentiation was induced by an adipogenic cocktail for 5 days,
Ankrd26 down-regulation caused a 2.5-fold increase in adipogen-
esis compared to the control cells as shown by the accumulation of
triglycerides in the cells (Figure 3B and C), indicating that the
down-regulation of Ankrd26, as well as its partial ablation [8],
modulates differentiation in fat cells.
We then focused our attention on ANKRD26 partners TRIO,
which is a Rho and Rac activator and a LAR interacting partner
[9–11], GPS2, and DIPA, which have been reported to control
gene expression by inhibition of transcription [14,16,20] and
HMMR, which can regulate cell migratory behavior and mitosis
[17,18]. In 3T3-L1 cells, Trio shRNA induced a 60% decrease of
Trio mRNA levels (Figure 3D), and its down-regulation was
paralleled by a 5-fold increase in adipogenesis compared with a
control shRNA (Figure 3E and F). Gps2 shRNA produced an 80%
decrease of Gps2 mRNA levels (Figure 3G), and this strong down-
regulation was accompanied by a 3-fold increase in adipogenesis
(Figure 3H and I). HMMR shRNA produced a 74% decrease in
Figure 2. Protein interactions of ANKRD26 with TRIO, GPS2,
DIPA and HMMR. A) Immunoblot of whole cell lysates (input; lanes 1–
2 and 5–6) and IP (lanes 3–4 and 7–8) from 293/T cells over-expressing
Flag-ANKRD26-C (lanes 1–8) and TRIO-Myc (lanes 2, 4, 6 and 8). B)
Immunoblot of whole cell lysates (input; lanes 1–2 and 5–6) and IP
(lanes 3–4 and 7–8) from 293/T cells over-expressing Flag-ANKRD26-C
(lanes 1–8) and GPS2-Myc (lanes 2, 4, 6 and 8). C) Immunoblot of whole
cell lysates (input; lanes 1–2 and 5–6) and IP (lanes 3–4 and 7–8) from
293/T cells over-expressing Flag-ANKRD26-C (lanes 1–8) and DIPA-Myc
(lanes 2, 4, 6 and 8). D) Immunoblot of whole cell lysates (input; lanes 1–
2 and 5–6) and IP (lanes 3–4 and 7–8) from 293/T cells over-expressing
Flag-ANKRD26-C (lanes 1–8) and HMMR-Myc (lanes 2, 4, 6 and 8). IP
were performed using the anti-Myc antibody as described in Methods.
Left blots were probed with anti-Myc antibody, while right blots were
striped and then probed with anti-Flag antibody.
doi:10.1371/journal.pone.0038130.g002
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increase in adipogenisis (Figure 3K and L). Finally, when Dipa
shRNA was transfected in 3T3-L1 cells, a 60% decrease of Dipa
mRNA levels was observed (Figure 3M), and Dipa down-regulation
caused a modest increase in adipogenesis (Figure 3N and O).
These data confirm the role of DIPA as a negative regulator of
adipogenesis [16], but more importantly they identify TRIO,
GPS2 and HMMR as new proteins that also negatively regulate
the adipogenic process in 3T3-L1 cells.
GPS2 and DIPA localization in transfected 3T3-L1 cells
Both GPS2 and DIPA have been previously found to localize to
the nucleus [16,20]. To investigate the effect of ANKRD26 on the
localization of both GPS2 and DIPA proteins, confocal immuno-
fluorescence studies were performed in 3T3-L1 cells individually
over-expressing GPS2-Myc or DIPA-Myc proteins, or simulta-
neously over-expressing Flag-ANKRD26-C with GPS2-Myc or
DIPA-Myc proteins. As shown in Figure 4Ai and Bi, both GPS2-
myc and DIPA-myc proteins are localized in the nuclei of cells
transfected with pcDNA3.1-GPS2-Myc and pcDNA3.1-DIPA-
Myc, respectively. When co-transfected with Flag-ANKRD26-C,
which is mainly located in the cytosol (Figure 4Av and viii), GPS2-
Myc mostly co-localized with Flag-ANKRD26-C in the cytoplasm
of 3T3-L1 cells (Figure 4Aiv–vi). Similarly, when the DIPA-Myc
protein was expressed together with Flag-ANKRD26-C the
location of DIPA was predominantly in the cytoplasm
(Figure 4Biv–vi). These data confirm our finding that GPS2 and
DIPA interact with ANKRD26 and provide a possible mechanism
by which ANKRD26 can regulate the activity of these two
proteins by removing them from the nucleus in 3T3-L1 cells.
We previously reported that full-length ANKRD26 is mainly
located close to the plasma membrane, although some can be
detected in the cytoplasm. To investigate if the full-length protein
could decrease the amount of DIPA or GPS2 in the nucleus, cells
were transfected with GPS2-myc or DIPA-myc and full-length
ANKRD26. Unfortunately, very few transfected cells were found
to express ANKRD26 and we could not get an answer to this
question.
Expression of Ankrd26, Trio, Gps2, HMMR and Dipa
during adipogenic induction in 3T3-L1 cells
To determine if the expression of endogenous Ankrd26 and its
interacting partners were altered during adipogenesis in 3T3-L1
cells, we performed Real Time quantitative PCR using RNA
isolated from 3T3-L1 treated with an adipogenic cocktail at
various time points as described in the Methods. As shown in
Figure 5, Ankrd26 expression increased 2-fold in the post-
confluent cells as compared to pre-confluent condition and
remains unchanged during adipogenic induction. Trio expression
increased almost 3-fold in post-confluent condition and then
remained at that level. Gps2 levels were increased at post-
confluence but then fell to a pre-confluent level during early time
points of cocktail treatment and then increased at day 8 as
compared to pre-confluent cells. HMMR expression increased
almost 3-fold in post-confluent condition and its levels remained
high up to day 8. The expression of Dipa was increased almost 4-
fold at day 2 of induction and remained high until day 4 but
decreased on day 8 of adipogenic induction. These results indicate
that the expression of Ankrd26, as well as the expression of its
interacting partners is differentially regulated during adipogenesis.
Discussion
In the present work, we identified 13 potential interacting
partners for ANKRD26 by yeast two-hybrid screening, and
validated as novel ANKRD26 interacting proteins TRIO, GPS2,
DIPA, and HMMR by co-immunoprecipitation assays in mam-
malian cells. Furthermore, our analysis of adipogenesis showed
that the selective down-regulation of Ankrd26, Trio, Gps2, Hmmr
and Dipa, increased adipocyte differentiation upon induction in
3T3-L1 cells. These finding indicated that ANKRD26, TRIO,
GPS2, HMMR and DIPA are regulators of adipogenesis. Further,
GPS2 and DIPA proteins, that usually are located in the nucleus,
become translocated into the cytoplasm when co-transfected with
the C-terminus of ANKRD26 in 3T3-L1 cells, suggesting that the
C-terminus may modulate the localization and function of these
two proteins. However, due to our inability to transfect the very
large full-length Ankrd26 cDNA into cells, we do not know if the
full-length protein will have a similar interaction with the
interacting proteins or change the nuclear localization of DIPA
and GPS2. In addition we do not know if the interaction of one of
the interacting partners affects the interaction of other interacting
proteins with the carboxy-terminus of Ankrd26. Studies are
underway to determine the binding site for each of the interacting
proteins on Ankrd26.
The ANKRD26 gene was originally identified as the ancestor of
primate specific ANKRD30A and the POTE gene family [21]. It
maps to chromosome 10p12.1 and encodes a protein of 192 kDa,
which is located close to the inner aspect of the plasma membrane
[6]. The ANKRD26 protein contains two conserved domains:
Ankyrin repeats, located from amino acids 74–199, and helical
regions (743–1538), which are structurally similar to the a-spectrin
family proteins [6]. The presence of these two domains, known to
mediate protein-protein interactions [22,23], suggested that
ANKRD26 might play a role as an adaptor protein [6]. From
the two-hybrid screening data only one protein (ANKRD17) was
found to interact with the ankyrin repeat region at the N-terminus
of ANKRD26; all the other 12 proteins interacted with region
901–1702 of ANKRD26 that contains the spectrin-like coiled-coil
domains. These findings indicate that the coiled-coil domain at the
C-terminus of ANKRD26 rather than Ankyrin domain is mainly
involved in ANKRD26 protein-protein interactions, and is likely
to be responsible for its biological functions. In support of this last
statement are our previous data obtained in mutant mice [6,7], in
which removal of the region encoding amino acids 1212–1710,
encompassing part of the spectrin like helices and all the C-
terminus of Ankrd26, cause extreme hyperphagia and severe
obesity [6]. Furthermore, Ankrd26 mutant mice develop an
unusual form of obesity-induced diabetes in which white adipose
Figure 3. shRNA knockdown of Ankrd26, Trio, Gps2, HMMR and Dipa induces adipocyte differentiation in 3T3-L1 cells. To down-regulate
Ankrd26, Trio, Gps2, HMMR and Dipa expression cells were transfected with specific shRNA for Ankrd26 (Ankrd-sh), Trio (Trio-sh), Gps2 (Gps2-sh),
HMMR (HMMR-sh), Dipa (Dipa-sh) or with non-targeting control shRNA (Co-sh). A) Ankrd26 mRNA expression determined by Real-Time Quantitative
PCR analysis of total RNA isolated from 3T3-L1 cells transfected with Ankrd-sh or Co-sh. mRNA levels in Ankrd-sh treated cells are relative expression
units to those in control (Co-sh; mean 6 SD; n=3). **p,0.01. Macroscopic images (B) and lipid quantification (C) in Ankrd-sh and Co-sh transfected
cells stained with oil-red-O upon differentiation. Bars are expressed as means 6 SEM of oil-red-O values measured at 490 nm. Ankrd-sh vs. Co-sh,
**p,0.01. mRNA expression (D, G, J and M), macroscopic images (E, H, K and N) and lipid quantification (F, I, L and O) of 3T3-L1 cells transduced
with Trio-sh (D–F), Gps2-sh (G–I), HMMR-sh (J–L) and Dipa-sh (M–O) were evaluated as A, B and C, respectively.
doi:10.1371/journal.pone.0038130.g003
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body insulin resistance, and shows an improved sensitivity to the
hormone when the mutant mice were pair fed with normal mice
[7]. These data indicate that the C-terminus of Ankrd26 has at
least two functions: one is to control the response to insulin in
white adipose tissue; the other is to control appetite and satiety.
Recently we demonstrated that partial disruption of the Ankrd26
gene regulates adipocyte differentiation both at the level of
progenitor commitment and at early and late differentiation steps
in MEF cells from Ankrd26 mutant mice and that this process is
associated with ERK-1/2 activation [8]. Here we show that down-
regulation of Ankrd26 expression caused an increase in adipogen-
esis when 3T3-L1 cells were transfected with a specific shRNA for
the murine endogenous Ankrd26. All together these findings
indicate that Ankrd26 has an important role in regulating
differentiation of adipocytes.
The protein TRIO was initially identified as a binding partner
for LAR, a trans-membrane protein tyrosine phosphatase. Its
association with LAR was suggested to play a key role in the
integration of diverse signals needed for cell-matrix interaction and
cytoskeletal rearrangements during cell migration [9–11]. TRIO is
a multidomain protein, which contains two guanine nucleotide
exchange factor domains that promote Rho and Rac1 activation,
and a serine/threonine kinase domain [9]. Furthermore, TRIO
also possesses two pleckstrin homology domains that can recruit
TRIO to different membranes, and four spectrin-like domains and
an Ig-like domain that can mediate protein-protein interactions
[9]. Here, we identified TRIO as a novel ANKRD26 interacting
protein and we demonstrated for the first time the involvement of
Figure 4. Nuclear localization of GPS2 and DIPA is affected in 3T3-L1 cells over-expressing Flag-ANKRD26-C. A) 3T3-L1 cells
transfected with GPS2-Myc (i–ix) and Flag-ANKRD26-C vectors (iv–ix) were double stained with antibodies against anti-Myc (i, iv, vii) and anti-Flag (ii,
v, viii) and with DAPI solution for the nucleus staining (iii, vi, ix). B) 3T3-L1 cells transfected with DIPA-myc (i–ix) and Flag-ANKRD26-C vectors (iv–ix)
were stained as in B. The images labeled iii, vi and ix are the merged fluorescent images. Note that only co-transfected cells in Panels vii, viii and ix
demonstrate cytosolic localization on GPS2 and DIPA.
doi:10.1371/journal.pone.0038130.g004
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Although the mechanism by which TRIO can inhibit adipogen-
esis, and how ANKRD26 can interfere with the function of TRIO
are not yet known and are under investigation. We suggest that
TRIO could regulate adipogenesis in combination with LAR and/
or through the activation of Rho GTPase signaling. In support of
this hypothesis are the recent reports that LAR and Rho signaling
are negative regulators of adipogenesis [24,25]. Kim et al. reported
in human mesenchymal stem cells and in 3T3-L1 cells that the
knock-down of endogenous LAR induced a dramatic increase of
adipogenesis in these cells, while its over-expression caused a
strong reduction of adipogenic differentiation by inhibition of
insulin/insulin receptor signaling [24]. On the other hand,
Sordella et al. reported that the modulation of Rho GTPase
signaling regulates a switch between adipogenesis and myogenesis
[25]. Indeed, mice lacking the Rho inhibitory protein p190-B
RhoGAP exhibit a complete absence of mature adipocytes and
MEF cells derived from these mice are defective in adipogenesis
and this defect is rescued by inhibiting Rho kinase. Furthermore,
the introduction of excessive Rho activity in MEF cells from
control mice and in 3T3-L1 cells is sufficient to disrupt
adipogenesis [25].
We have also shown that the selective down-regulation of the
expression of three other ANKRD26 interacting partners, GPS2,
HMMR and DIPA, enhances the proportion of differentiated
cells. GPS2 was originally identified based on its ability to suppress
lethal G protein subunit-activating mutations in the yeast
pheromone responsive pathway [12], and its over-expression in
mammalian cells potentially suppresses a RAS- and MAPK-
mediated signal and interferes with JNK activity [12,13]. Most
importantly, GPS2 was found as an integral subunit of N-CoR-
HDAC3 complex. It interacts directly with N-CoR and transduc-
ing beta-like protein 1 (TbL1) proteins inside the complex and it is
essential for its assembly and stabilization [14]. It was recently
demonstrated that the adipogenic transcription factor proliferator-
activated receptor gamma (PPARc) recruits N-CoR in the absence
of its ligand, and that this co-repressor down-regulates PPARc
transcriptional activity. Furthermore, the silencing of N-CoR
increases the expression of adipocyte specific genes and of
adipogenesis in 3T3-L1 cells [26]. Similarly, PPARc recruits
HDAC3 to maintain transcriptional repression of its target genes
[27]. Our findings demonstrate for the first time that GPS2 can act
as a repressor of adipogenesis in 3T3-L1 cells and that its
sequestration from the nucleus mediated by ANKRD26 may
inhibit its function. Whether this regulatory process is mediated by
GPS2 alone or in combination with the other proteins of the N-
CoR-HDAC3 complex remain to be clarified.
The protein DIPA was initially identified as an interacting
protein for the viral HDAg and it was shown to affect hepatitis D
virus replication in vitro [15]. Bezy et al. recently described DIPA
also as a novel interacting partner for the adipocyte transcription
factors C/EBPb and d. They showed that over-expression of
DIPA affects adipogenesis in 3T3-L1 cells; while its silencing
enhances this process as we also showed in our study. Further-
more, they demonstrated that DIPA can co-localize with these two
Figure 5. Analysis of Ankrd26, Trio, Gps2, HMMR and Dipa RNA by
rq-pcr during adipogenesis induction. 3T3-L1 cells plated 6-well
plates (1.8610
5/well) and harvested at various time points as: day 1
(pre-confluence), day 2 (confluence), day 4 (2 days after confluence),
day 5 (IDM induction day 1), day 6 (IDM induction day 2), day 8 (IDM
induction day 4), day12 (IDM induction day 8). RNA made by Trizol
regent and subjected to Real Time Quantitative PCR using SYBR
method. Bar represents triple for each sample.
doi:10.1371/journal.pone.0038130.g005
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modulate their transcriptional activity inhibiting adipogenesis [16].
Thus, our findings confirm the role of DIPA as negative regulator
of this process and support the possible role of ANKRD26 as
counter-regulator of DIPA mechanism by regulating DIPA
localization.
HMMR is an oncogenic protein implicated in the progression of
many human cancers, such as breast, gastric, and prostate cancers
[28]. It was originally identified as a soluble protein, which binds to
CD44 or hyaluronan and promotes cell motility and invasion
through sustained stimulation of the activity of ERK1/2 kinase
[18,28–30]. Within the cell, HMMR plays a role in the regulation of
mitosis through its association with microtubules [17], and it
regulates the normal development of breast epithelial cells forming a
complex with BRCA1 [31]. Furthermore it was recently shown that
intracellular HMMR performs scaffolding functions to control both
activityand targetingofERK1/2totubulin [32].Here,weidentified
HMMR as a novel ANKRD26 interacting partner and we showed
for the first time its involvement as regulator of adipogenesis.
Although how HMMR inhibits adipocyte differentiation and how
ANKRD26 interferes with HMMR function remain to be clarified,
we suggest that it could involve HMMR’s ability to modulate
ERK1/2activation.Itshouldbenotedthattheadipogenicinduction
in 3T3L1 is consistently higher during selective knock down of each
oftheinteractingpartnersofAnkrd26yettheendogenousexpression
of those proteins are not consistently lower during the adipogenic
induction suggesting the involvement of multiple pathways and
complex interaction of these interacting proteins in vivo.
In summary, we have identified several novel proteins that
participate in the regulation of adipogenisis and we have shown that
the region at the C-terminus of ANKRD26 that contains spectrin-
likehelicesisresponsibleforitsinteractionwiththeseproteinsandin
its regulation of adipogenesis. The identity of the residues that are
responsible for the specific binding between ANKRD26 and its
newly identified partners and the mechanism by which these
proteins regulate adipogenisis are under investigation.
Materials and Methods
Yeast two-hybrid analysis
Yeast two-hybrid screening and analysis was performed by
Myriad Genetics. Briefly, a bait construct expressing various
fragments of ANKRD26 protein was fused to the C-terminus of a
Gal4 DNA binding domain (residues 1–147). Each bait was
transformed into the yeast strain PNY200. Prey constructs,
expressing cDNA from human brain, testis or mouse embryo
mRNA fused to the C-terminus of a Gal4 activation domain
(amino acids (aa) 768–881), were transformed into yeast strain
BK100. PNY200 cells (bait) were mated with BK100 cells (prey),
and the desired diploid cells with positive interaction were selected
with appropriate selectable marker. Interactions were further
confirmed by transforming bait and prey constructs into naı ¨ve
yeast cells and performing liquid culture b-galactosidase assays.
293/T cells: culture conditions and transient transfection
293/T cells (ATCC) were maintained in DMEM media
(Quality Biologicals) supplemented with 10% FBS (Quality
Biologicals), 2 mM L-Glutamine, 1 mM sodium pyruvate and
1% penicillin-streptomycin solutions in a humidified 5% CO2
incubator at 37uC. For transient transfection, expression vectors
for pcDNA3.1-Flag-ANKRD26-C (aa 1212–1710), pcDNA3.1-
DIPA-Myc, pcDNA3.1-GPS2-Myc, pcDNA3.1-TRIO-Myc and
pcDNA3.1-HMMR-Myc were transfected individually or in
combination into 293/T cells using lipofectamine reagent
(Invitrogen) following the manufacturer’s protocol. Cells were
lysed 48 hr after transfection (see below).
Cell lysate preparation, IP and western blot (WB) analysis
Both 293/T and 3T3-L1 (ATCC) cells were harvested and
washed in PBS, and then lysed in Lysis Buffer containing 20 mM
Tris-HCl, pH7.5, 150 mM NaCl, 5 mM EDTA, 1% NP40, 5 mg/
ml leupeptin, 5 mg/ml aprotinin, 10 mM PMSF. Samples were
incubated on ice 30 min after the addition of Lysis Buffer and then
cell lysates were clarified by centrifugation at 15,000 g for 10 min
at 4uC. The protein concentration of the cell lysate was
determined using the Coomassie blue protein assay (Bio-Rad
Laboratories). Protein lysates were then analyzed by SDS-PAGE,
transferred to a PVDF membrane and subjected to WB analysis.
For each IP experiment about 1 mg of protein lysate from 293/T
cells transfected with the various combinations of vectors was
incubated with 1.5 mg of anti-myc antibody (Sigma Aldrich) for
2h r a t 4 uC. After incubation, 40 ml of protein A sepharose
(Invitrogen) in a 1:1 mixture of protein A sepharose and Lysis
Buffer were added to the IP samples. Purified interacting complex
was released from protein A sepharose beads by boiling in SDS-
PAGE sample buffer and resolved on a 4–20% Tris-glycine gel.
Samples were then subjected to WB analysis. Membranes were
firstly probed with antibodies to Myc (Sigma Aldrich), Flag M2
(Sigma Aldrich), PPARc (Santa Cruz Inc), C/EBPa (Cell
Signaling), and b-tubulin (Sigma Aldrich) and then with secondary
mouse or rabbit antibodies (GE Healthcare) before detection of
the signal with ECL plus (GE Healthcare).
Oil-red-o staining
Lipid droplets in differentiating or mature adipocytes were
stained with the oil-red-O method as described [8]. Oil-red-O
stained cells were scanned to obtain macroscopic pictures of cells.
Cells were finally eluted with absolute isopropanol and the
extracted red dye was measured with spectrophotometer at
490 nm.
ShRNA and siRNA transduction
1.10
5 3T3-L1 cells were transduced with specific shRNA
lentivirus particles for Ankrd26 (TRCN0000254144), Trio
(TRCN0000254107), Gps2 (TRCN0000037101), Dipa
(TRCN0000248678), HMMR (TRCN0000071589) and for the
control shRNA SHC002V. All shRNA were purchased from
Sigma Aldrich. After 3 days cells were selected with puromycin for
10 days. The puramycin-resistant cells were then collected,
maintained in selection media and adipogenesis was induced as
previously described.
Immunofluorescence
3T3-L1 cells transfected with pcDNA3.1-Flag-ANKRD26-C,
pcDNA3.1-DIPA-Myc and pcDNA3.1-GPS2-Myc expression
vectors were fixed in 4% formalin solution, subjected to
membrane permeabilization with PBS containing 0.1% Tri-
tonX-100, and then blocked for 1 hr in PBS containing 5% FBS
and 3% BSA. Cells were than incubated with rabbit anti-myc
and/or mouse anti-Flag antibodies for 2 hr at RT. After washing,
cells were then incubated for 1 h with secondary antibody-
fluorochrome-labeled (Alexa Fluor 594 anti-mouse IgG and Alexa
Fluor 488 goat anti-rabbit IgG; Invitrogen). Cells were then
washed and incubated in a DAPI solution for 10 min to stain the
nucleus. Finally, slides were mounted with cover slip and observed
on the Zeiss 510 confocal microscope (Carl Zeiss).
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Total RNA extraction, cDNA synthesis and Real Time
quantitative PCR were performed as described [8]. Quantitative
PCR analysis of cells in the presence of corresponding shRNA was
performed using mRNA isolated from cells before adding the
adipogenic cocktail for differentiation. Primer sequences are listed
in Table 2.
Statistical analysis
Data are expressed as means 6 SEM and statistical significance
between groups was analyzed by 2-tailed Student’s t test. P values
of ,0.05 were considered statistically significant.
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